Multimodal assessment of retinal status in Alzheimer disease and frontotemporal dementia using advanced ophthalmic imaging techniques: a review
Ophthalmology Reports · 22.10.2026 · 19 (3) · 87-99
DOI: 10.17816/ov707331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Reports, online erschienen am 22.10.2026. Verfasst von Ksenia V. Kundryukova und 11 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer disease and frontotemporal dementia are clinically and pathobiologically heterogeneous neurodegenerative disorders. Their early verification is hampered by the limited availability, invasiveness, and poor reproducibility of traditional biomarkers. This review summarizes current data on retinal biomarkers detected using optical coherence tomography, in particular optical coherence tomography angiography, molecular ophthalmic imaging, and digital image analysis, as applied to the early diagnosis and differential assessment of Alzheimer disease and frontotemporal dementia. It has been established that the retina, being embryologically, anatomically, and functionally linked to the central nervous system, reflects key processes of neurodegeneration, microvascular remodeling, disruption of neurovascular interactions, and accumulation of pathological proteins. For Alzheimer disease, the most reproducible features are thinning of the inner retinal layers, decreased vascular density and perfusion, enlargement of the foveal avascular zone, and amyloid- and tau-associated markers. For frontotemporal dementia, by contrast, the outer retinal degeneration type appears most promising, primarily thinning of the outer nuclear layer and the layer of the inner segments of cones and rods, which may have differential diagnostic value. Functional ophthalmological parameters, tear and intraocular biomarkers, and the capabilities of artificial intelligence models in processing multimodal images are considered separately. Thus, retinal imaging represents a promising noninvasive basis for risk stratification, early diagnosis, and monitoring of neurodegenerative dementias. However, its clinical implementation requires standardization of protocols, consideration of ophthalmological and systemic comorbid factors, and multicenter longitudinal studies with confirmation of reproducibility.
Zitieren
APA
Kundryukova, K. V., Guzaerov, I. F., Zentsova, V. S., Gerasenkova, A. V., Gumerova, D. I., Morozova, V. A., Shamsutdinova, D. I., Mingaleeva, N. E., Akhmetzianov, A. I., Kadyrova, D. D., Novikov, I. D., & Oshchepkov, M. A. (2026). Multimodal assessment of retinal status in Alzheimer disease and frontotemporal dementia using advanced ophthalmic imaging techniques: a review. Ophthalmology Reports, 19(3), 87-99. https://doi.org/10.17816/ov707331
Vancouver
Kundryukova KV, Guzaerov IF, Zentsova VS, Gerasenkova AV, Gumerova DI, Morozova VA, et al. Multimodal assessment of retinal status in Alzheimer disease and frontotemporal dementia using advanced ophthalmic imaging techniques: a review. Ophthalmology Reports. 2026;19(3):87-99. doi:10.17816/ov707331
BibTeX
@article{Kundryukova2026,
author = {Kundryukova, Ksenia V. and Guzaerov, Islam F. and Zentsova, Valeriya S. and Gerasenkova, Anna V. and Gumerova, Diana I. and Morozova, Veronika A. and Shamsutdinova, Diana I. and Mingaleeva, Nargiz E. and Akhmetzianov, Airat I. and Kadyrova, Dinara D. and Novikov, Ivan D. and Oshchepkov, Maksim A.},
title = {Multimodal assessment of retinal status in Alzheimer disease and frontotemporal dementia using advanced ophthalmic imaging techniques: a review},
journal = {Ophthalmology Reports},
year = {2026},
volume = {19},
number = {3},
pages = {87--99},
doi = {10.17816/ov707331}
}
EUVIMED